New Frontiers in Esophagogastric Cancer with Dr. Yelena Janjigian

The treatment of esophagogastric cancer is undergoing a profound transformation. In this episode, Yelena Janjigian, MD (MSKCC), discusses how perioperative chemoimmunotherapy and precision biomarkers are redefining the standard of care. Key highlights include: - The Perioperative Shift: Why starting immunotherapy before surgery is achieving unprecedented pathologic responses. - Precision Testing: The essential role of MSI, PD-L1, HER2, and CLDN18.2 testing for every patient. - Avoiding Understaging: Why clinical evaluation must go beyond imaging to prevent missed therapeutic opportunities. - Multidisciplinary Success: The critical need for surgeon-oncologist communication before the first incision. Tune in to learn why "cure" is the new benchmark in localized disease and how to integrate these advances into your clinical practice today. Interested in the complete CE activity? Complete Module 1: Complete Module 2:

You can listen to New Frontiers in Esophagogastric Cancer with Dr. Yelena Janjigian online on Radio and Podcast. Open the player on this page to stream the available audio.

New Frontiers in Esophagogastric Cancer with Dr. Yelena Janjigian is an episode from Oncology Data Advisor by Oncology Data Advisor™.

This episode is 00:08:14 long.

This episode was published on Apr 8, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Oncology Data Advisor when more episodes are available from the podcast feed.